194 related articles for article (PubMed ID: 33123604)
21. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
23. Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury.
Jin Y; Li J; Chen J; Shao M; Zhang R; Liang Y; Zhang X; Zhang X; Zhang Q; Li F; Cheng Y; Sun X; He J; Li Z
J Immunol Res; 2019; 2019():3642937. PubMed ID: 31205955
[TBL] [Abstract][Full Text] [Related]
24. No association of single nucleotide polymorphisms within H19 and HOX transcript antisense RNA (HOTAIR) with genetic susceptibility to systemic lupus erythematosus, rheumatoid arthritis, and primary Sjögren's syndrome in a Chinese Han population.
Huang AF; Su LC; Jia H; Liu Y; Xu WD
Clin Rheumatol; 2017 Nov; 36(11):2447-2453. PubMed ID: 28914367
[TBL] [Abstract][Full Text] [Related]
25. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
Padern G; Duflos C; Ferreira R; Assou S; Guilpain P; Maria ATJ; Goulabchand R; Galea P; Jurtela M; Jorgensen C; Pers YM
Front Immunol; 2021; 12():631539. PubMed ID: 33708222
[TBL] [Abstract][Full Text] [Related]
26. Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.
Wang Y; Chen S; Chen J; Xie X; Gao S; Zhang C; Zhou S; Wang J; Mai R; Lin Q; Lin J; Matucci-Cerinic M; Zhang G; Furst DE
Ann Rheum Dis; 2020 Feb; 79(2):268-275. PubMed ID: 31848144
[TBL] [Abstract][Full Text] [Related]
27. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
Zhang FC; Liu L; Xu D
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
[TBL] [Abstract][Full Text] [Related]
28. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
[TBL] [Abstract][Full Text] [Related]
29. CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations.
Hong J; Cheng H; Wang P; Wu Y; Lu S; Zhou Y; Wang XB; Zhu X
Arthritis Res Ther; 2024 Jan; 26(1):26. PubMed ID: 38229121
[TBL] [Abstract][Full Text] [Related]
30. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus.
Wu GC; Hu Y; Guan SY; Ye DQ; Pan HF
Biomolecules; 2019 May; 9(6):. PubMed ID: 31141998
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren's syndrome.
Mona M; Mondello S; Hyon JY; Saleh W; Han K; Lee HJ; Ha YJ; Kang EH; Lee YJ; Cha S
Clin Exp Rheumatol; 2021; 39(4):795-803. PubMed ID: 33124573
[TBL] [Abstract][Full Text] [Related]
33. Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.
Imgenberg-Kreuz J; Almlöf JC; Leonard D; Sjöwall C; Syvänen AC; Rönnblom L; Sandling JK; Nordmark G
Front Immunol; 2019; 10():1686. PubMed ID: 31428085
[No Abstract] [Full Text] [Related]
34. Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sjögren's syndrome.
Cornec D; Saraux A; Pers JO; Jousse-Joulin S; Marhadour T; Roguedas-Contios AM; Genestet S; Renaudineau Y; Devauchelle-Pensec V
Arthritis Res Ther; 2014 Jan; 16(1):R15. PubMed ID: 24433480
[TBL] [Abstract][Full Text] [Related]
35. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
[TBL] [Abstract][Full Text] [Related]
36. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
37. Elevated expression of interleukin-37 in patients with rheumatoid arthritis.
Yuan ZC; Wang JM; Huang AF; Su LC; Li SJ; Xu WD
Int J Rheum Dis; 2019 Jun; 22(6):1123-1129. PubMed ID: 30843355
[TBL] [Abstract][Full Text] [Related]
38. Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome.
Ranta N; Valli A; Grönholm A; Silvennoinen O; Isomäki P; Pesu M; Pertovaara M
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):47-50. PubMed ID: 29465367
[TBL] [Abstract][Full Text] [Related]
39. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
[TBL] [Abstract][Full Text] [Related]
40. Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome.
Li YN; Guo JP; He J; Liu X; Yin FR; Ding Y; Yao HH; Kang AJ; Li ZG
Chin Med J (Engl); 2011 Aug; 124(16):2490-5. PubMed ID: 21933593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
